Company Analysis U.S. Physical Therapy, Inc.
1. Summary
Advantages
- Dividends (1.86%) are higher than the sector average (1.3%).
- Current debt level 17.7% is below 100% and has decreased over 5 years from 24.57%.
- The company's current efficiency (ROE=3.08%) is higher than the sector average (ROE=-82.41%)
Disadvantages
- Price (87.72 $) is higher than fair price (8.9 $)
- The stock's return over the last year (-23.76%) is lower than the sector average (-15.59%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| U.S. Physical Therapy, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -3.8% | -13.2% | -3.2% |
| 90 days | -18% | -16.1% | -7.4% |
| 1 year | -23.8% | -15.6% | 9.7% |
USPH vs Sector: U.S. Physical Therapy, Inc. has significantly underperformed the "Healthcare" sector by -8.17% over the past year.
USPH vs Market: U.S. Physical Therapy, Inc. has significantly underperformed the market by -33.5% over the past year.
Stable price: USPH is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: USPH with weekly volatility of -0.4569% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (87.72 $) is higher than the fair price (8.9 $).
Price is higher than fair: The current price (87.72 $) is 89.9% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (91.42) is lower than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (91.42) is higher than that of the market as a whole (73.51).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.06) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (2.06) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.22) is lower than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (2.22) is lower than that of the market as a whole (15.92).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (16.98) is lower than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (16.98) is lower than that of the market as a whole (22.62).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -14.41% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-14.41%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (3.08%) is higher than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (3.08%) is lower than that of the market as a whole (25.01%).
5.5. ROA
ROA vs Sector: The company's ROA (1.43%) is lower than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (1.43%) is lower than that of the market as a whole (6.62%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 1.86% is higher than the average for the sector '1.3%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.86% has been steadily paid over the past 7 years, DSI=0.93.
Weak dividend growth: The company's dividend yield 1.86% has been growing weakly or stagnant over the past 5 years. Growth over only 3 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (164.43%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Selling More insider purchases by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 07.03.2025 | REEVE GRAHAM D. COO |
Sale | 82.11 | 142 050 | 1 730 |
| 09.12.2024 | HENDRICKSON CAREY P Chief Financial Officer |
Sale | 96.25 | 49 665 | 516 |
| 22.11.2024 | Richard S. Binstein Officer |
Purchase | 98 | 117 600 | 1 200 |
| 08.11.2024 | Graham Reeve COO |
Purchase | 96.29 | 166 004 | 1 724 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
